[Value of determining plasma INH during antitubercular treatment. Retrospective analysis of 204 cases].

J C Cheminat, M Paire, J Lavarenne, C Ducarrouge, C Molina
{"title":"[Value of determining plasma INH during antitubercular treatment. Retrospective analysis of 204 cases].","authors":"J C Cheminat,&nbsp;M Paire,&nbsp;J Lavarenne,&nbsp;C Ducarrouge,&nbsp;C Molina","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The acetylator phenotype of 204 tuberculous patients was assessed (152 men and 52 women aged between 15 and 90). The INH dose was adjusted according to Vivien's protocol, measuring the index of inactivation of Isoniazid I3, three hours after the oral dose. In fixing the transition zone of I3 at 0.50 the distribution between slow and rapid acetylators was 53% and 47% respectively. There was no difference for sex, age or ethnic group. The dosage used according to this protocol varied greatly, going from 1.64 mg/kg/day to 13.3 mg/kg/day with a mean value of 2.74 mg/kg/day for slow acetylators and 6.13 mg/kg/day for rapid acetylators. The usual dose advised is 5 mg/kg/day, which may lead equally to over or under treatment though the former is more likely in our experience. Adjusting the dosage is an important feature in good tolerance of the treatment: indeed only 4 of 86 subjects whose dosage has been adjusted showed elevated transaminases, whereas 34 of 118 patients had raised transaminases in the control group on a standard dose before the adjusted treatment was introduced. The difference was significant between the two groups.</p>","PeriodicalId":76480,"journal":{"name":"Revue francaise des maladies respiratoires","volume":"11 6","pages":"867-73"},"PeriodicalIF":0.0000,"publicationDate":"1983-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue francaise des maladies respiratoires","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The acetylator phenotype of 204 tuberculous patients was assessed (152 men and 52 women aged between 15 and 90). The INH dose was adjusted according to Vivien's protocol, measuring the index of inactivation of Isoniazid I3, three hours after the oral dose. In fixing the transition zone of I3 at 0.50 the distribution between slow and rapid acetylators was 53% and 47% respectively. There was no difference for sex, age or ethnic group. The dosage used according to this protocol varied greatly, going from 1.64 mg/kg/day to 13.3 mg/kg/day with a mean value of 2.74 mg/kg/day for slow acetylators and 6.13 mg/kg/day for rapid acetylators. The usual dose advised is 5 mg/kg/day, which may lead equally to over or under treatment though the former is more likely in our experience. Adjusting the dosage is an important feature in good tolerance of the treatment: indeed only 4 of 86 subjects whose dosage has been adjusted showed elevated transaminases, whereas 34 of 118 patients had raised transaminases in the control group on a standard dose before the adjusted treatment was introduced. The difference was significant between the two groups.

血浆INH测定在抗结核治疗中的价值。204例回顾性分析]。
对204例结核患者(男性152例,女性52例,年龄在15 - 90岁之间)的乙酰化表型进行了评估。根据Vivien方案调整INH剂量,测定口服后3小时异烟肼I3的失活指数。将I3的过渡区固定在0.50时,慢速和快速乙酰化剂的分布分别为53%和47%。性别、年龄和种族没有差异。根据该方案使用的剂量变化很大,从1.64 mg/kg/天到13.3 mg/kg/天,慢速乙酰化剂的平均值为2.74 mg/kg/天,快速乙酰化剂的平均值为6.13 mg/kg/天。通常建议的剂量是5mg /kg/天,这可能导致治疗过量或治疗不足,尽管根据我们的经验,前者更有可能。调整剂量是治疗良好耐受性的一个重要特征:事实上,在86名调整剂量的受试者中,只有4名显示转氨酶升高,而在引入调整治疗之前,118名使用标准剂量的对照组中,有34名患者转氨酶升高。两组之间的差异是显著的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信